Webinar 1 Characterizing the Pathologic Triad of Cardiorenal Anemia Syndrome
IV Iron in CRAS - Core Clinical Concepts
•
19m
Cardiorenal Anemia Syndrome (CRAS) involves the complex interplay of heart failure, chronic kidney disease, and anemia. Over 40% of heart failure patients experience CRAS, complicating their management. Anemia worsens both heart failure and chronic kidney disease, with inflammation and hepcidin playing key roles in iron deficiency. Addressing iron deficiency is crucial for improving patient outcomes and understanding the relationships among these conditions.
Up Next in IV Iron in CRAS - Core Clinical Concepts
-
Webinar 2 Deconstructing the Vicious ...
Cardiorenal Anemia syndrome presents a complex challenge, particularly in managing iron deficiency. Effective iron supplementation is crucial, with hepcidin playing a key role in iron homeostasis. Clinical trials show that next-generation IV iron products outperform oral iron in treating heart fa...
-
Webinar 3 An Infusion of Change in th...
The final session on cardiorenal anemia syndrome focuses on treatment strategies to improve patient outcomes. It covers intravenous iron formulations, their dosing, and indications, while emphasizing the importance of recognizing adverse drug reactions. A patient case study highlights the managem...
-
Understanding Cardiorenal Syndrome an...
A Dr Brendan nephrologist, discusses key concepts of Cardiorenal syndrome and iron deficiency. He explains how chronic inflammation in patients with heart failure and chronic kidney disease affects iron absorption, making intravenous iron crucial. Recent trials show that intravenous iron reduces ...
